Biosafety and hazardous shipping training; NIH/FDA/CDC/OSHA regulatory compliance; Chairman, Biosafety Risk Assessment Sub-Committee for Harvard's IBC - Committee on Microbiological Safety.

Gene therapy protocol writing consultant and IBC reviewer.

Provide general biomedical research laboratory biosafety training and individualized lentiviral vector biosafety training; provide OSHA Blood Borne Pathogen Training and blood and tissue sample shipping training to Clinical Research Coordinators; designed rDNA registration forms for IBC registration and review; pre-IBC scientific and biosafety review of NIH OBA-compliant rDNA registrations (new and renewals); perform laboratory Biosafety audits; provide adenovirus, retrovirus and lentivirus vector biosafety training for technicians, supervisors, and Quality Control and Quality Assurance personnel for human gene transfer clinical trials laboratory; member Dana-Farber Blood-Borne Pathogen Exposure Reduction team.

Project Leader for multisite collaborative preclinical AIDS vaccine development.

Biosafety regulatory writing; immunologist